All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition
During the EHA2021 Virtual Congress, the Lymphoma Hub spoke with Caroline Besson, Université de Paris, Paris, FR. We asked, How does COVID-19 impact patients with lymphoma receiving B-cell-depleting immunotherapy?
How does COVID-19 impact patients with lymphoma receiving B-cell-depleting immunotherapy?
In this video, Besson discusses the outcomes of a trial looking at patients with lymphoma and COVID-19 infection, including duration of hospitalization, mortality rates, and comorbidities.
The effect of COVID-19 on the management of patients with lymphoma
A summary of recommendations for patients with lymphoma during the COVID-19 pandemic provided by Executive Steering Committee Member Stefano Luminari.
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease
During the American Association of Cancer Research (AACR) virtual meeting, the Lymphoma Hub was pleased to speak to Christine...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox